Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7-pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix

European Journal of Gynaecological Oncology

Volumn 21, Issue 1, 2000, Pages 17-23

  Santin, Alessandro D ^a,b,c   Hermonat, P L ^d   Ravaggi, A ^b   Bellone, S ^b   Cowan, C ^a   Korourian, S ^a   Pecorelli, S ^b   Cannon, M J ^a   Parham, G P ^a  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^d NONE

Author keywords

Adoptive immunotherapy; Cervical cancer; CTLs; Dentritic cells; HPV

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ALPHA INTERFERON; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ADOPTIVE TRANSFER; ADULT; ARTICLE; CASE REPORT; CELL TRANSFORMATION; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG METASTASIS; LYMPHOBLAST; METASTASIS; MONONUCLEAR CELL; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; RADIOACTIVITY; SCINTILLATION CAMERA; T LYMPHOCYTE; TUMOR CELL; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADENOCARCINOMA; ADULT; ANTIGENS, CD56; ANTIGENS, CD8; DENDRITES; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033952052     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bosch F. X., Manos M. M., Munoz N. et al.: "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective". J. Natl. Cancer Inst., 1995, 87, 796.
2. Brinton L. A.: "Epidemiology of cervical cancer: overview". In: N. Munoz, F. Bosch, K. V. Shah, A. Meheus (eds.): The epidemiology of human papillomavirus and cervical cancer. Lyon, France; IARC Science Publications, 1992, 119, 3.
3. Steinman R. M.: "The dendritic cell system and its role in immunogenicity". Ann. Rev. Immunol., 1991, 9, 271.
4. Young J. W., Inaba K.: "Dendritic cells as adjuvants for Class I major histocompatibility complex-restricted antitumor immunity". J. Exp. Med., 1996, 183, 7.
5. Romani N., Gruner S., Brang D. et al.: "Proliferating dendritic cell progenitors in human blood". J. Exp. Med., 1994, 180, 83.
6. Santin A. D., Hermonat P. L., Ravaggi A. et al.: "Induction of human papillomavirus-specific CD4+ and CD8+ lymphocytes by E7 pulsed autologous dendritic cells in patients with HPV16 and 18 positive cervical cancer". J. Virol., 1999, 73, 5402.
7. McIntrye M. C., Ruesch M. N., Laimins L. A.: "Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107". Virology, 1996, 215, 73.
8. Hopkins K. A.: "Basic microlymphocytotoxicity test". In: "ASHI manual". Lenexa (KS), American Society for Histocompatibility and Immunogenetics, 1990, 195.
9. Openshaw P. J. M., Murphy E. E., Hosken N. A. et al.: "Heterogeneity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and T helper 2 populations". J. Exp. Med., 1995, 182, 1357.
10. Lu P.-H., Negrin R. S.: "A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency". J. Immunol., 1994, 153, 1687.
11. Takii Y., Hashimoto S., Iiai T., Watanabe H., Hatakeyama K., Abo T.: "Increase in the proportion of granulated CD56+ T cells in patients with malignancy". Clin. Exp. Immunol., 1994, 97, 522.
12. Satoh M., Seki S., Hashimoto W. et al.: "Cytotoxic γ/δ or α/β T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2". J. Immunol., 1996, 157, 3886.
13. von Boehmer H., Kirberg J., Rocha B.: "An unusual lineage of α/β T cells that contains autoreactive cells". J. Exp. Med., 1991, 174, 1001.
14. Rocha B., Vassalli P., Guy-Grand D.: "The extrathymic T cell development pathway". Immunol. Today, 1992, 13, 449.
15. Doherty P. C., Tripp R. E., Sixbey J. W.: "Evasion of host immune responses by tumors and viruses". In: "Vaccines Against Virally Induced Cancers". Wiley, Chichester (Ciba Foundation Symposium, 187), 1994, 245.
16. Durst M., Glitz D., Schneider A., zur Hausen A.: "Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridisation". Virology, 1992, 189, 132.
17. Yukawa K., Butz K., Yasui T., Kikutani H., Hoppe-Seyler F.: "Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1 skn-1a". J. Virol., 1996, 70, 10.
18. Chambers M. A., Wei Z., Coleman N., Nash A. A., Stanley M. A.: "'Natural' presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponiveness". Eur. J. Immunol., 1994, 24, 738.
19. Melero I., Singhal M. C., McGowan P. et al.: "Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus 16". J. Virol., 1997, 71, 3998.
20. Moretta A., Pantaleo G., Mingari M. C., Melioli G., Moretta L., Cerottini J.-C.: "Assignment of human natural killer (NK) like cells to the T-cell lineage. Single allospecific T-cell clones lyse specific or NK-sensitive target cells via distinct recognition structures". Eur. J. Immunol., 1984, 14, 121.
21. Thiele D. L., Lipsky P. E.: "The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells". Immunol. Today, 1989, 10, 375.
22. Hilders C. G. J. M., Ras L., Van Eendenburg J. D. H., Nooyen Y., Fleuren G. J.: "Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma". Int. J. Cancer, 1994, 57, 805.
23. 111oxine labelled human lymphocytes collected by automated apheresis". J. Nucl. Med., 1986, 31, 999.
24. 111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy". Cancer, 1994, 73, 1731.
25. Hsu F. J., Benike C., Fagnoni F. et al.: "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells". Nature Med., 1996, 2, 52.
26. Nestle F. O., Alijagic S., Gilliet M. et al.: "Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells". Nature Med., 1998, 4, 328.